Skip to content
Abivax
Primary Menu
About Us
Company
Management Team
Board of Directors
Scientific Advisory Board
Science
Overview
Publications
Pipeline
Overview
ABX464 for UC
ABX464 for HIV
ABX196 for HCC
ABX544 for Ebola Virus
News & Events
Press Releases
Press Coverage
Upcoming Events
Investors
Overview
Share Price
Investor Documents
Annual General Meeting
UEG Week 2019
Contact Us
Search
Search for:
Search
EN
FR
DE
Investors
Investor Documents
ABIVAX Announces the Registration of its Reference Document by AMF
May 19, 2015
ABIVAX Launches IPO on the Regulated Market of Euronext in Paris
June 9, 2015
Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised
June 23, 2015
1
…
8
9
10
Investor Contact
Chris Maggos
LifeSci Advisors
Chris@lifesciadvisors.com
+41 79 367 6254